妊娠期表观遗传衰老的纵向变化及其与不良结局的关联
这项前瞻性队列研究纳入2020—2021年寻求产科或妇科诊疗的未产女性,用11种DNA甲基化时钟测量表观遗传年龄。妊娠女性在6种时钟上呈现显著的个体内表观遗传年龄加速,每200天加速1.58至5.28年;妊娠早期GrimAge2每增加1年,复合妊娠并发症的调整比值比为1.36(95%CI 1.01-1.84)。
要点
- 妊娠女性在Hannum、PhenoAge、GrimAge、GrimAge2、干细胞分裂、DunedinPACE六种时钟上表观遗传年龄加速。
- 妊娠早期GrimAge2每增加1年,复合妊娠并发症风险增加36%(aOR 1.36,95%CI 1.01-1.84)。
- 实足年龄与复合妊娠并发症无关联(aOR 1.00,95%CI 0.83-1.21)。
核心结论
- 妊娠使个体内表观遗传衰老加速最多5.3年。
- 妊娠早期GrimAge2较高而非实足年龄较高,与复合妊娠并发症相关。
- 作者认为妊娠可能影响生物学衰老,并支持进一步研究表观遗传年龄作为妊娠健康潜在标志物。
研究设计与样本
- 前瞻性队列研究,纳入2020—2021年寻求产科(妊娠10-14周)或妇科(非妊娠)诊疗的未产女性,年龄18-50岁。
- 入组时(时间1)及产后第1天(妊娠组,时间2)或7个月后(非妊娠组,时间2)采血。
- 用Illumina EPIC 2芯片的11种已建立时钟测量表观遗传年龄。
- 共75名女性入组,45名(60.0%)妊娠,61名(81.3%)完成研究。
主要发现
- 妊娠女性在6种时钟(Hannum、PhenoAge、GrimAge、GrimAge2、干细胞分裂、DunedinPACE)上较非妊娠女性呈现显著的个体内表观遗传年龄加速。
- 妊娠队列每200天额外表观遗传年龄加速从1.58年(Hannum,95%CI 0.45-2.72,P=.01)至5.28年(PhenoAge,95%CI 2.97-7.61,P<.01)。
- 妊娠早期GrimAge2每增加1年,复合妊娠并发症的调整比值比为1.36(95%CI 1.01-1.84)。
- 实足年龄(连续年)与复合妊娠并发症无关联(aOR 1.00,95%CI 0.83-1.21)。
关键数值与推荐
- 复合妊娠并发症包括高血压疾病、妊娠期糖尿病、37周前早产和小于胎龄儿出生体重。
- 混合效应线性回归模型校正混杂因素和间隔天数,结果按200天间隔缩放,P值经多重检验校正。
- 多变量logistic回归校正时间1时年龄和体质指数(BMI)大于30。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To understand the relationship between pregnancy and epigenetic aging estimated by DNA methylation "clocks," which offers a molecular measure of biologic aging. METHODS: This was a prospective cohort study of nulliparous women (age 18-50 years) seeking obstetric (pregnant 10-14 weeks) or gynecologic (nonpregnant) care in 2020-2021. Blood was collected at enrollment (time 1) and postpartum day 1 (pregnant, time 2) or 7 months later (nonpregnant, time 2). Epigenetic age was measured with 11 established clocks from Illumina EPIC 2 arrays. Within-person changes in epigenetic age were compared with mixed-effects linear regression models adjusted for confounders and interval duration (days). Results were scaled per 200-day interval. P values were corrected for multiple testing. Multivariable logistic regression explored associations between first-trimester epigenetic age and a composite of potentially immune-mediated complications (hypertensive disorders, gestational diabetes mellitus, preterm birth before 37 weeks of gestation, and small-for-gestational-age birth weight) adjusted for age and body mass index (BMI) higher than 30 at time 1. RESULTS: In total, 75 women enrolled; 45 (60.0%) were pregnant, and 61 (81.3%) completed the study. Pregnant women exhibited significant within-person epigenetic age acceleration compared with nonpregnant women in six clocks (Hannum, PhenoAge, GrimAge, GrimAge2, Stem Cell Division, DunedinPACE). Additional epigenetic age acceleration per 200 days in the pregnant cohort ranged from 1.58 years (Hannum, 95% CI, 0.45-2.72, P =.01) to 5.28 years (PhenoAge, 95% CI, 2.97-7.61, P <.01). Each additional year of first-trimester GrimAge2 increased odds of the composite of pregnancy complications by 36% (adjusted odds ratio [aOR] 1.36, 95% CI, 1.01-1.84), while chronologic age (in continuous years) showed no association (aOR 1.00, 95% CI, 0.83-1.21). CONCLUSION: Pregnancy accelerated within-person epigenetic aging by up to 5.3 years. Older first-trimester GrimAge2, but not chronologic age, was associated with a composite of pregnancy complications. These findings suggest that gestation may influence biologic aging and support further investigation into epigenetic age as a potential marker of pregnancy health.
引用
- Panelli DM, Gladish N, Perlman NC, et al. Longitudinal Epigenetic Aging in Pregnancy and Associations With Adverse Outcomes. Obstet Gynecol. 2025. PMID: 40638919. doi:10.1097/AOG.0000000000006000
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。